Medical countermeasures drive pharma innovation: US officials
This article was originally published in Scrip
Executive Summary
While the initial US response to the current Ebola crisis got off to a bumpy start, the fact there are two vaccines in efficacy trials in West Africa and several drugs in development against the deadly disease is proof the medical countermeasure (MCM) system is working, top officials insisted during testimony at a 26 February Capitol Hill hearing.